Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination.

Haralambieva IH, Oberg AL, Dhiman N, Ovsyannikova IG, Kennedy RB, Grill DE, Jacobson RM, Poland GA.

J Infect Dis. 2012 Nov 15;206(10):1512-20. doi: 10.1093/infdis/jis546.

2.

Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination.

Haralambieva IH, Oberg AL, Ovsyannikova IG, Kennedy RB, Grill DE, Middha S, Bot BM, Wang VW, Smith DI, Jacobson RM, Poland GA.

PLoS One. 2013 May 1;8(5):e62149. doi: 10.1371/journal.pone.0062149.

3.

Genetic variation in IL18R1 and IL18 genes and Inteferon γ ELISPOT response to smallpox vaccination: an unexpected relationship.

Ovsyannikova IG, Haralambieva IH, Kennedy RB, O'Byrne MM, Pankratz VS, Poland GA.

J Infect Dis. 2013 Nov 1;208(9):1422-30. doi: 10.1093/infdis/jit341.

4.

Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.

Pittman PR, Garman PM, Kim SH, Schmader TJ, Nieding WJ, Pike JG, Knight R, Johnston SC, Huggins JW, Kortepeter MG, Korman L, Ranadive M, Quinn X, Meyers MS.

Vaccine. 2015 Jun 12;33(26):2990-6. doi: 10.1016/j.vaccine.2015.04.062.

PMID:
25930115
5.

Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine.

Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

J Infect Dis. 2011 Jun 1;203(11):1546-55. doi: 10.1093/infdis/jir167.

6.

Immunomodulator-based enhancement of anti smallpox immune responses.

Martínez O, Miranda E, Ramírez M, Santos S, Rivera C, Vázquez L, Sánchez T, Tremblay RL, Ríos-Olivares E, Otero M.

PLoS One. 2015 Apr 13;10(4):e0123113. doi: 10.1371/journal.pone.0123113.

7.

Correlations between vaccinia-specific immune responses within a cohort of armed forces members.

Umlauf BJ, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

Viral Immunol. 2011 Oct;24(5):415-20. doi: 10.1089/vim.2011.0029.

8.

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.

Frey SE, Winokur PL, Salata RA, El-Kamary SS, Turley CB, Walter EB Jr, Hay CM, Newman FK, Hill HR, Zhang Y, Chaplin P, Tary-Lehmann M, Belshe RB.

Vaccine. 2013 Jun 24;31(29):3025-33. doi: 10.1016/j.vaccine.2013.04.050.

9.

Transcriptomic profiles of high and low antibody responders to smallpox vaccine.

Kennedy RB, Oberg AL, Ovsyannikova IG, Haralambieva IH, Grill D, Poland GA.

Genes Immun. 2013 Jul-Aug;14(5):277-85. doi: 10.1038/gene.2013.14.

10.

The smallpox vaccine induces an early neutralizing IgM response.

Moyron-Quiroz JE, McCausland MM, Kageyama R, Sette A, Crotty S.

Vaccine. 2009 Dec 10;28(1):140-7. doi: 10.1016/j.vaccine.2009.09.086.

11.

Genome-wide association study of antibody response to smallpox vaccine.

Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, Poland GA.

Vaccine. 2012 Jun 13;30(28):4182-9. doi: 10.1016/j.vaccine.2012.04.055.

12.

HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study.

Ovsyannikova IG, Pankratz VS, Salk HM, Kennedy RB, Poland GA.

Hum Genet. 2014 Sep;133(9):1083-92. doi: 10.1007/s00439-014-1449-x.

13.

Antiviral immunity following smallpox virus infection: a case-control study.

Hammarlund E, Lewis MW, Hanifin JM, Mori M, Koudelka CW, Slifka MK.

J Virol. 2010 Dec;84(24):12754-60. doi: 10.1128/JVI.01763-10.

14.

Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans.

Haralambieva IH, Ovsyannikova IG, Dhiman N, Kennedy RB, O'Byrne M, Pankratz VS, Jacobson RM, Poland GA.

J Infect Dis. 2011 Aug 1;204(3):433-41. doi: 10.1093/infdis/jir268.

15.

Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination.

Ovsyannikova IG, Haralambieva IH, Kennedy RB, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA.

Gene. 2012 Nov 15;510(1):59-65. doi: 10.1016/j.gene.2012.08.021.

16.

Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.

Nishiyama Y, Fujii T, Kanatani Y, Shinmura Y, Yokote H, Hashizume S.

Vaccine. 2015 Nov 9;33(45):6120-7. doi: 10.1016/j.vaccine.2015.09.067.

17.

Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.

Trojan A, Rajeswaran R, Montemurro M, Mütsch M, Steffen R.

J Clin Virol. 2007 Sep;40(1):80-3.

PMID:
17644471
18.

Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arrays.

Oberg AL, Dhiman N, Grill DE, Ryan JE, Kennedy RB, Poland GA.

J Immunol Methods. 2011 Mar 7;366(1-2):69-78. doi: 10.1016/j.jim.2011.01.011.

19.

Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.

Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.

J Virol. 2008 Apr;82(7):3517-29. doi: 10.1128/JVI.01854-07.

20.

The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.

Kim SH, Yeo SG, Park KH, Bang JW, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW.

Clin Microbiol Infect. 2007 Jan;13(1):91-3.

Items per page

Supplemental Content

Support Center